Floatz logo

IRON SUCCINATE (FE(O4C4H4))

Iron-deficiency

Beijing Tiantan HospitalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Iron-deficiency cohort.

Asset / SponsorPhaseRating
FERRIC CATION
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4A
Iron Isomaltoside
China-Japan Friendship Hospital
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB

View all 13 →

Same molecule, other indications

IRON SUCCINATE (FE(O4C4H4)) is also rated in:

Hematopoietic Stem Cell TransplantationDormant
BB
Indicative ·
65 / 100
View asset →
AnemiaDormant
BB
Indicative ·
65 / 100
View asset →
Phenylketonuria (PKU)Dormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →